🔗 Permalink

Inventor profile of:

Mark G. ERLANDER

City:

Encinitas, California

Country:

United States

Published Applications:

Last publication date:

2017-10-05

Top Assignees for applications by Mark G. ERLANDER

The entities that hold a legal rights for patent applications filed by inventor ERLANDER Mark G.:

BIOTHERANOSTICS, INC. 5 San Diego, CA United States
AviaraDx, Inc. 5 Carlsbad, CA United States
Arcturus Bioscience, Inc. 4 Mountain View, CA United States
LIFE TECHNOLOGIES CORPORATION 3 Carlsbad, CA United States
Ortho-McNeil Pharmaceutical, Inc. 3 Raritan, NJ United States
The General Hospital Corporation 2 Boston, MA United States
Arcturus Engineering, Inc. 1 Mountain View, CA United States
GENERAL HOSPITAL CORPORATION 1 Boston, MA United States
AVIARADX, INC. 1 San Diego, CA United States
MDS Analytical Technologies (US) Inc. 1 Sunnyvale, CA United States
Molecular Devices Corporation 1 Sunnyvale, CA United States

Recent patent applications by ERLANDER Mark G.

Mark G. ERLANDER from Encinitas, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-10-05

US20170286596A1

Physics

Identification of tumors and tissues

#2 | 2012-12-27

US20120329097A1

Chemistry; metallurgy

NUCLEIC ACID AMPLIFICATION

#3 | 2012-12-20

US20120322113A1

Chemistry; metallurgy

NUCLEIC ACID AMPLIFICATION

#4 | 2011-04-14

US20110086394A1

Chemistry; metallurgy

Nucleic Acid Amplification

#5 | 2010-08-05

US20100197511A1

Chemistry; metallurgy

Gene expression profiling from FFPE samples

#6 | 2010-02-25

US20100047787A1

Chemistry; metallurgy

PROSTATE CANCER SURVIVAL AND RECURRENCE

#7 | 2009-10-29

US20090270271A1

Chemistry; metallurgy

3' Biased Detection of Nucleic Acids

#8 | 2009-08-27

US20090215037A1

Physics

Dynamically expressed genes with reduced redundancy

#9 | 2009-04-09

US20090092973A1

Chemistry; metallurgy

Grading of breast cancer

#10 | 2009-03-26

US20090082215A1

Chemistry; metallurgy

Gene expression profiling from FFPE samples

#11 | 2008-04-29

US10329282

Gene expression profiling from FFPE samples

#12 | 2007-01-25

US20070020655A1

Physics

Identification of Tumors and Tissues

#13 | 2006-12-21

US20060286579A1

Chemistry; metallurgy

NORMALIZATION GENES

#14 | 2006-11-23

US20060263806A1

Physics

BIOMARKERS FOR BREAST CANCER

#15 | 2006-11-02

US20060246434A1

Chemistry; metallurgy

Nucleic acid amplification

#16 | 2006-10-19

US20060234287A1

Physics

BREAST CANCER PROGRESSION SIGNATURES

#17 | 2006-08-22

US10090215

Human vanilloid receptor VR3 protein

#18 | 2005-11-17

US20050255481A1

Chemistry; metallurgy

Progesterone receptor transcript sequences

#19 | 2005-10-27

US20050239083A1

Chemistry; metallurgy

Predicting breast cancer treatment outcome

#20 | 2005-10-27

US20050239079A1

Chemistry; metallurgy

Predicting outcome with tamoxifen in breast cancer

#21 | 2005-09-22

US20050208500A1

Chemistry; metallurgy

Signatures of ER status in breast cancer

#22 | 2005-06-16

US20050130194A1

Chemistry; metallurgy

Nucleic acid amplification

#23 | 2005-06-09

US20050124795A1

Chemistry; metallurgy

Human 5-HT3-C protein

#24 | 2005-05-12

US20050100933A1

Physics

Breast cancer survival and recurrence

#25 | 2005-04-21

US20050084897A1

Chemistry; metallurgy

Human vanilloid receptor VR3 protein

#26 | 2005-01-20

US20050014168A1

Chemistry; metallurgy

3' biased microarrays

#27 | 2005-01-13

US20050009047A1

Chemistry; metallurgy

Global linear non-biased nucleic acid amplification

InventorID:

2004048 ⎘